Multiple Risk Factors for Cardiovascular Disease and Diabetes Mellitus

American Journal of Medicine

Volumn 120, Issue 3 SUPPL. 1, 2007, Pages

  Smith Jr , Sidney C ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Cardiovascular risk; Metabolic syndrome; Obesity; Type 2 diabetes mellitus

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; HEALTH SURVEY; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK FACTOR; UNITED STATES; WAIST CIRCUMFERENCE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; GREAT BRITAIN; HUMANS; METABOLIC SYNDROME X; OBESITY; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 33847063390     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2007.01.002     Document Type: Article

References (34)

1. National Heart, Lung, and Blood Institute, National Institutes of Health. Fact Book for Fiscal Year 2002 (2003), US Dept of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD. http://www.nhlbi.nih.gov/about/02factbk.pdf Available at: http://www.nhlbi.nih.gov/about/02factbk.pdf. Accessed June 2006.
2. American Obesity Association. AOA Fact Sheets: Obesity in the U.S. (2002), American Obesity Association, Washington, DC. http://www.obesity.org/subs/fastfacts/obesity_US.shtml Available at: http://www.obesity.org/subs/fastfacts/obesity_US.shtml. Accessed June 2006.
3. Mokdad A.H., Marks J.S., Stroup D.F., and Gerberding J.L. Actual causes of death in the United States, 2000. JAMA 291 (2004) 1238-1245
4. Olshansky S.J., Passaro D.J., Hershow R.C., et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352 (2005) 1138-1145
5. Bhatt D.L., Steg P.G., Ohman E.M., et al., REACH [Reduction of Atherothrombosis for Continued Health] Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295 (2006) 180-189
6. Yusuf S., Hawken S., Ounpuu S., et al., INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
7. Mokdad A.H., Ford E.S., Bowman B.A., et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care 23 (2000) 1278-1283
8. Mokdad A.H., Serdula M.K., Dietz W.H., Bowman B.A., Marks J.S., and Koplan J.P. The continuing epidemic of obesity in the United States. JAMA 284 (2000) 1650-1651
9. Mokdad A.H., Serdula M.K., Dietz W.H., Bowman B.A., Marks J.S., and Koplan J.P. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 282 (1999) 1519-1522
10. Mokdad A.H., Bowman B.A., Ford E.S., Vinicor F., Marks J.S., and Koplan J.P. The continuing epidemics of obesity and diabetes in the United States. JAMA 286 (2001) 1195-1200
11. Mokdad A.H., Ford E.S., Bowman B.A., et al. The continuing increase of diabetes in the U.S. [letter]. Diabetes Care 24 (2001) 412
12. Unal B., Critchley J.A., and Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 109 (2004) 1101-1107
13. Critchley J.A., and Capewell S. Why model coronary heart disease?. Eur Heart J 23 (2002) 110-116
14. Capewell S., Beaglehole R., Seddon M., and McMurray J. Explanation for the decline in coronary heart disease mortality in Auckland, New Zealand, between 1982 and 1993. Circulation 102 (2000) 1511-1516
15. Capewell S., Morrison C.E., and McMurray J.J. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 81 (1999) 380-386
16. Yan L.L., Daviglus M.L., Liu K., et al. Midlife body mass index and hospitalization and mortality in older age. JAMA 295 (2006) 190-198
17. National Heart, Lung, and Blood Institute, National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report (1998), National Institutes of Health, Bethesda, MD. http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf NIH Publication No. 98-4083. Available at: http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf. Accessed June 2006.
18. Peeters A., Barendregt J.J., Willekens F., Mackenbach J.P., Al Mamun A., Bonneux L., NEDCOM, and the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 138 (2003) 24-32
19. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., Lenfant C., and Conference Participants. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition [NHLBI/AHA Conference Proceedings]. Circulation 109 (2004) 433-438
20. Katzmarzyk P.T., Janssen I., Ross R., Church T.S., and Blair S.N. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 29 (2006) 404-409
21. Grundy S.M. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 81 (1998) 18B-25B
22. Reaven G.M. Banting Lecture 1998: role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
23. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
25. Lorenzo C., Okoloise M., Williams K., Stern M.P., and Haffner S.M. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 26 (2003) 3153-3159
26. Ridker P.M., Wilson P.W., and Grundy S.M. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?. Circulation 109 (2004) 2818-2825
27. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
28. Ninomiya J.K., L'Italien G., Criqui M.H., Whyte J.L., Gamst A., and Chen R.S. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 109 (2004) 42-46
29. Sattar N., Gaw A., Scherbakova O., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
30. Wei M., Gaskill S.P., Haffner S.M., and Stern M.P. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans: a 7-year prospective study. Obes Res 5 (1997) 16-23
31. Stevens J., Couper D., Pankow J., et al. Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obes Res 9 (2001) 696-705
32. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
33. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
34. Eckel R.H., Kahn R., Robertson R.M., and Rizza R.A. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 113 (2006) 2943-2946